title: Type 2 diabetes mellitus, oral diabetic medications, insulin therapy, and overall breast cancer risk.
abstract: Breast cancer is among the most common cancers worldwide. Diabetes is an important chronic health problem associated with insulin resistance, increased insulin level, changes in growth hormones and factors, and activation of mitogen-activating protein kinase (MAPK) pathways, leading to an increased breast cancer risk. This paper looked at the epidemiologic studies of the association between type 2 diabetes and risk of breast cancer and its effect on overall cancer-specific survival. The combined evidence overall supported a modest association between type 2 diabetes and the risk of breast cancer, which was found to be more prevalent among postmenopausal women. Effect of oral diabetics and insulin therapy on breast cancer risk was also evaluated. It was found that metformin and thiazolidinones tended to have a protective role. Metformin therapy trials for its use as an adjuvant for breast cancer treatment are still ongoing. Sulfonylurea and insulin therapy were found to be mildly associated with increased overall cancers. No evidence or studies evaluated the association of DPPIV inhibitors and GLP 1 agonists with breast cancer risk because of their recent introduction into the management of diabetes.
authors: Division of Endocrinology and Metabolism, Department of Internal Medicine, American University of Beirut Medical Center, Beirut, Lebanon.
authors: Hala
authors: H
authors: Ahmadieh
authors: Sami T
authors: ST
authors: Azar
references: Cancer Causes Control. 2004 Apr;15(3):267-75
references: 15090721
references: Cancer Causes Control. 2010 Jun;21(6):879-87
references: 20148361
references: Exp Diabetes Res. 2012;2012:789174
references: 22701472
references: Br J Cancer. 2012 Oct 23;107(9):1608-17
references: 22996614
references: Am J Epidemiol. 2002 Aug 15;156(4):349-52
references: 12181105
references: Breast Cancer Res Treat. 2010 Sep;123(2):591-6
references: 20300828
references: Eur J Cancer. 1990;26(7):781-5
references: 2145895
references: Diabetes. 2006 May;55(5):1369-79
references: 16644694
references: Int J Epidemiol. 1999 Oct;28(5):816-23
references: 10597976
references: Curr Diabetes Rev. 2009 May;5(2):92-101
references: 19442094
references: Int J Cancer. 1997 May 2;71(3):360-3
references: 9139868
references: Clin Oncol. 1978 Sep;4(3):243-9
references: 750127
references: Breast Cancer Res Treat. 2006 Aug;98(3):349-56
references: 16541321
references: Int J Cancer. 2007 Aug 15;121(4):856-62
references: 17397032
references: Exp Diabetes Res. 2012;2012:413782
references: 22719752
references: Diabetes. 2010 Mar;59(3):686-93
references: 19959755
references: Diabetes Care. 2003 Jun;26(6):1752-8
references: 12766105
references: Eur J Endocrinol. 2012 Oct;167(4):589-99
references: 22893694
references: Oncologist. 2012;17(4):485-91
references: 22467665
references: Circ Res. 2007 Feb 16;100(3):328-41
references: 17307971
references: Pharmacoepidemiol Drug Saf. 2007 May;16(5):485-92
references: 17192841
references: Breast. 2009 Oct;18(5):299-303
references: 19800794
references: Breast Cancer Res Treat. 2009 Jan;113(1):101-11
references: 18256928
references: Cancer Immunol Immunother. 2011 Sep;60(9):1221-5
references: 21681370
references: Asian Pac J Cancer Prev. 2012;13(1):139-46
references: 22502657
references: Breast Cancer Res Treat. 2012 Oct;135(3):639-46
references: 22847511
references: J Clin Endocrinol Metab. 2012 Jul;97(7):E1170-5
references: 22563104
references: Epidemiology. 1994 Jan;5(1):102-8
references: 8117767
references: J Intern Med. 1997 Jun;241(6):471-5
references: 10497622
references: Diabetologia. 2011 Sep;54(9):2254-62
references: 21614572
references: Cancer Epidemiol Biomarkers Prev. 2009 Mar;18(3):701-5
references: 19240238
references: Cancer Causes Control. 2012 May;23(5):769-77
references: 22467266
references: Cancer Causes Control. 1991 Sep;2(5):307-14
references: 1932543
references: Int J Cancer. 1974 Aug 15;14(2):153-60
references: 4378317
references: J Clin Oncol. 2012 Aug 10;30(23):2844-52
references: 22689798
references: Acta Diabetol. 2009 Dec;46(4):279-84
references: 19082520
references: N Engl J Med. 2012 Jul 26;367(4):319-28
references: 22686416
references: Cancer Cell. 2007 Jul;12(1):9-22
references: 17613433
references: Med Oncol. 2012 Sep;29(3):1576-80
references: 22083554
references: Diabetes Care. 2011 Dec;34(12):2542-4
references: 21972408
references: Arch Gynakol. 1975 Dec 16;220(1):73-81
references: 1243526
references: J Chronic Dis. 1982;35(1):13-9
references: 7068798
references: Int J Cancer. 1990 Oct 15;46(4):751-2
references: 2210889
references: BMJ. 2005 Jun 4;330(7503):1304-5
references: 15849206
references: Eur J Cancer. 2010 Sep;46(13):2369-80
references: 20656475
references: Cell Cycle. 2009 Aug 15;8(16):2661
references: 19571669
references: Diabetes Care. 2010 Jun;33(6):1304-8
references: 20299480
references: Ann Oncol. 2012 Jul;23(7):1771-80
references: 22112968
references: Diabetes Care. 2006 Feb;29(2):254-8
references: 16443869
references: Schweiz Med Wochenschr. 1991 Jan 9;121(1-2):30-6
references: 1990420
references: Breast Cancer Res Treat. 2003 Jun;79(3):391-7
references: 12846423
references: Diabetes Care. 2009 Sep;32(9):1620-5
references: 19564453
references: J Clin Oncol. 2009 Jul 10;27(20):3297-302
references: 19487376
references: Health Care Women Int. 2011 Nov;32(11):953-71
references: 21978143
references: Curr Drug Targets Immune Endocr Metabol Disord. 2003 Sep;3(3):205-9
references: 12871027
references: Horm Cancer. 2012 Aug;3(4):137-46
references: 22528451
references: Ann Oncol. 2010 Jan;21(1):187-9
references: 19884247
references: Cancer Prev Res (Phila). 2010 Sep;3(9):1077-83
references: 20810669
references: Exp Diabetes Res. 2012;2012:732027
references: 22919369
references: Arch Surg. 1986 Nov;121(11):1322-5
references: 2946276
references: J Chronic Dis. 1985;38(5):435-41
references: 3998058
references: Br J Cancer. 1994 Nov;70(5):950-3
references: 7947103
references: Cancer Epidemiol Biomarkers Prev. 2011 Jan;20(1):101-11
references: 21119073
references: Cancer Causes Control. 2012 Jul;23(7):1193-203
references: 22674293
references: Breast Cancer Res Treat. 2006 Aug;98(3):303-9
references: 16538527
references: J Surg Res. 2009 May 15;153(2):210-6
references: 18639247
references: Cancer Causes Control. 2012 Nov;23(11):1785-95
references: 22971998
references: Science. 2005 Dec 9;310(5754):1642-6
references: 16308421